MRC IAA Development of a bivalent nanobody to GPVI and human albumin as a novel anti-thrombotic therapy

Project Details

Short titleMRC IAA Development of a bivalent nanobody to GPVI and human albumin as a novel anti-thrombotic therapy
StatusActive
Effective start/end date1/02/2430/11/24

Funding

  • Medical Research Council